Massachusetts And Dusseldorf

Boston Scientific Announces Enrollment of First Patient in Benign Stricture Study of WallFlex(R) Biliary RX Stent

Older News

NATICK, Massachusetts and DUSSELDORF, Germany, January 15 - Boston Scientific Corporation (NYSE: BSX) today announced that the first patient has been enrolled in a clinical trial to evaluate its WallFlex(R) Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy